LCIG in treatment of non-motor symptoms in advanced Parkinson's disease: Review of literature.

Brain and Behavior
Walaa A Kamel, Jasem Y Al-Hashel

Abstract

For managing nonmotor symptoms (NMS) in advanced Parkinson's disease (PD), levodopa-carbidopa intestinal gel (LCIG) infusion is of interest as it shows lesser plasma fluctuations of both drugs as compared to oral levodopa-carbidopa (LC). To highlight LCIG effect in NMS among advanced PD patients and appraise the currently available literature. PubMed screening (till 2020) of 184 articles was done, of which 51 were selected. Among them, 23 original articles relevant to the research question were included, of which 6 were then excluded after careful reading of full articles. The 17 relevant studies of the review provide Grade C level of evidence of efficacy. LCIG is beneficial in improving or relieving various NMS especially (mood, cognition/memory, sleep, gastrointestinal symptoms, urinary symptoms, and quality of life questionnaires) in patients with advanced PD. Amelioration of motor functions or direct relations may lead to improvement in NMS PD patients using LCIG. Adverse events noted in patients treated with LCIG include pneumoperitoneum, abdominal pain, stoma infection, reversible peripheral neuropathy, local tube problems, impulse control disorder, and weight loss. Serious adverse events were mostly found to be unrelated...Continue Reading

References

Apr 30, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Hani T S BenamerDonald G Grosset
May 9, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Holger HonigK Ray Chaudhuri
Nov 12, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Claire L TomlinsonCarl E Clarke
Jun 14, 2012·Acta Neurologica Scandinavica·S E PålhagenA Johansson
Jan 15, 2013·Acta Neurologica Scandinavica·M ZibettiL Lopiano
Jan 31, 2014·Journal of Neurology·María T Cáceres-RedondoPablo Mir
Jun 19, 2015·Acta neurologica Belgica·F BellanteD Zegers de Beyl
Aug 15, 2015·PloS One·Bashayer R Al-MubarakNada A Al Tassan
Jan 19, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Florence C F ChangVictor S C Fung
May 25, 2016·Parkinsonism & Related Disorders·Aristide MerolaLeonardo Lopiano
Jul 22, 2016·Neurodegenerative Disease Management·Francesc ValldeoriolaJuan Carlos Parra
Feb 18, 2017·Journal of Parkinson's Disease·Ahmed A OthmanSandeep Dutta
Apr 21, 2017·Journal of Neurology·Maurizio ZibettiLeonardo Lopiano
May 24, 2017·Current Pharmacology Reports·Michael A Kelberman, Elena M Vazey
Aug 23, 2017·Brain and Behavior·Oriol De FabreguesJosé Alvarez-Sabín
Sep 28, 2017·PloS One·Srishti ShresthaHonglei Chen
Oct 19, 2017·Parkinsonism & Related Disorders·Angelo AntoniniUNKNOWN GLORIA study co-investigators
Dec 5, 2017·Brain and Behavior·Francesc ValldeoriolaEduardo Tolosa
Dec 16, 2017·Movement Disorders Clinical Practice·David G StandaertJanet Benesh
Jan 26, 2018·Neurology and Therapy·Mortimer Mamelak
Apr 30, 2019·Parkinson's Disease·John B WetmorePablo Martinez-Martin

❮ Previous
Next ❯

Citations

Apr 6, 2021·Journal of Parkinson's Disease·Anders Björklund, Malin Parmar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved